F C Wright1, L H Souter2, S Kellett2, A Easson3, C Murray4, J Toye5, D McCready3, C Nessim6, D Ghazarian7, N J Look Hong8, S Johnson6, D P Goldstein7, T Petrella1. 1. Odet te Regional Cancer Cent re, Toronto, ON. 2. Program in Evidence-Based Care, Hamilton, ON. 3. Princess Margaret Hospital, Toronto, ON. 4. Women's College Hospital, Toronto, ON. 5. Royal Victoria Regional Health Centre, Barrie, ON. 6. The Ottawa Hospital, Ottawa, ON. 7. Toronto General Hospital, Toronto, ON. 8. Sunnybrook Health Sciences Centre, Toronto, ON.
Abstract
Background: For patients who are diagnosed with early-stage cutaneous melanoma, the principal therapy is wide surgical excision of the primary tumour and assessment of lymph nodes. The purpose of the present guideline was to update the 2010 Cancer Care Ontario guideline on wide local excision margins and sentinel lymph node biopsy (slnb), including treatment of the positive sentinel node, for melanomas of the trunk, extremities, and head and neck. Methods: Using Ovid, the medline and embase electronic databases were systematically searched for systematic reviews and primary literature evaluating narrow compared with wide excision margins and the use of slnb for melanoma of the truck and extremities and of the head and neck. Search timelines ran from 2010 through week 25 of 2017. Results: Four systematic reviews were chosen for inclusion in the evidence base. Where systematic reviews were available, the search of the primary literature was conducted starting from the end date of the search in the reviews. Where systematic reviews were absent, the search for primary literature ran from 2010 forward. Of 1213 primary studies identified, 8 met the inclusion criteria. Two randomized controlled trials were used to inform the recommendation on completion lymph node dissection.Key updated recommendations include:■ Wide local excision margins should be 2 cm for melanomas of the trunk, extremities, and head and neck that exceed 2 mm in depth.■ slnb should be offered to patients with melanomas of the trunk, extremities, and head and neck that exceed 0.8 mm in depth.■ Patients with sentinel node metastasis should be considered for nodal observation with ultrasonography rather than for completion lymph node dissection. Conclusions: Recommendations for primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in patients with cutaneous melanoma have been updated based on the current literature.
Background: For patients who are diagnosed with early-stage cutaneous melanoma, the principal therapy is wide surgical excision of the primary tumour and assessment of lymph nodes. The purpose of the present guideline was to update the 2010 Cancer Care Ontario guideline on wide local excision margins and sentinel lymph node biopsy (slnb), including treatment of the positive sentinel node, for melanomas of the trunk, extremities, and head and neck. Methods: Using Ovid, the medline and embase electronic databases were systematically searched for systematic reviews and primary literature evaluating narrow compared with wide excision margins and the use of slnb for melanoma of the truck and extremities and of the head and neck. Search timelines ran from 2010 through week 25 of 2017. Results: Four systematic reviews were chosen for inclusion in the evidence base. Where systematic reviews were available, the search of the primary literature was conducted starting from the end date of the search in the reviews. Where systematic reviews were absent, the search for primary literature ran from 2010 forward. Of 1213 primary studies identified, 8 met the inclusion criteria. Two randomized controlled trials were used to inform the recommendation on completion lymph node dissection.Key updated recommendations include:■ Wide local excision margins should be 2 cm for melanomas of the trunk, extremities, and head and neck that exceed 2 mm in depth.■ slnb should be offered to patients with melanomas of the trunk, extremities, and head and neck that exceed 0.8 mm in depth.■ Patients with sentinel node metastasis should be considered for nodal observation with ultrasonography rather than for completion lymph node dissection. Conclusions: Recommendations for primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in patients with cutaneous melanoma have been updated based on the current literature.
Authors: G P Browman; M N Levine; E A Mohide; R S Hayward; K I Pritchard; A Gafni; A Laupacis Journal: J Clin Oncol Date: 1995-02 Impact factor: 44.544
Authors: Sandra L Wong; Mark B Faries; Erin B Kennedy; Sanjiv S Agarwala; Timothy J Akhurst; Charlotte Ariyan; Charles M Balch; Barry S Berman; Alistair Cochran; Keith A Delman; Mark Gorman; John M Kirkwood; Marc D Moncrieff; Jonathan S Zager; Gary H Lyman Journal: Ann Surg Oncol Date: 2017-12-13 Impact factor: 5.344
Authors: G Cohn-Cedermark; L E Rutqvist; R Andersson; M Breivald; C Ingvar; H Johansson; P E Jönsson; L Krysander; C Lindholm; U Ringborg Journal: Cancer Date: 2000-10-01 Impact factor: 6.860
Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries Journal: N Engl J Med Date: 2014-02-13 Impact factor: 91.245
Authors: Kelly M McMasters; R Dirk Noyes; Douglas S Reintgen; James S Goydos; Peter D Beitsch; B Scott Davidson; Jeffrey J Sussman; Jeffrey E Gershenwald; Merrick I Ross Journal: J Surg Oncol Date: 2004-07-01 Impact factor: 3.454
Authors: Jeffrey Weber; Mario Mandala; Michele Del Vecchio; Helen J Gogas; Ana M Arance; C Lance Cowey; Stéphane Dalle; Michael Schenker; Vanna Chiarion-Sileni; Ivan Marquez-Rodas; Jean-Jacques Grob; Marcus O Butler; Mark R Middleton; Michele Maio; Victoria Atkinson; Paola Queirolo; Rene Gonzalez; Ragini R Kudchadkar; Michael Smylie; Nicolas Meyer; Laurent Mortier; Michael B Atkins; Georgina V Long; Shailender Bhatia; Celeste Lebbé; Piotr Rutkowski; Kenji Yokota; Naoya Yamazaki; Tae M Kim; Veerle de Pril; Javier Sabater; Anila Qureshi; James Larkin; Paolo A Ascierto Journal: N Engl J Med Date: 2017-09-10 Impact factor: 91.245
Authors: Andrew J Hayes; Lauren Maynard; Gillian Coombes; Julia Newton-Bishop; Michael Timmons; Martin Cook; Jeffrey Theaker; Judith M Bliss; J Meirion Thomas Journal: Lancet Oncol Date: 2016-01-12 Impact factor: 41.316
Authors: Vlad Alexandru Gâta; Andrei Roman; Maximilian Muntean; Dragoş Ştefan Morariu; Cătălin Ioan Vlad; Eduard Alexandru Bonci; Alexandru Irimie; Patriciu Achimaş-Cadariu Journal: Med Pharm Rep Date: 2022-01-31
Authors: Richard J B Walker; Nicole J Look Hong; Marc Moncrieff; Alexander C J van Akkooi; Evan Jost; Carolyn Nessim; Winan J van Houdt; Emma H A Stahlie; Chanhee Seo; May Lynn Quan; J Gregory McKinnon; Frances C Wright; Michail N Mavros Journal: Ann Surg Oncol Date: 2022-06-08 Impact factor: 4.339
Authors: Steffen Spoerl; Gerrit Spanier; Elena Reiter; Michael Gerken; Sebastian Haferkamp; Jirka Grosse; Konstantin Drexler; Tobias Ettl; Monika Klinkhammer-Schalke; René Fischer; Silvia Spoerl; Torsten E Reichert; Christoph Klingelhöffer Journal: Head Face Med Date: 2021-10-22 Impact factor: 2.246
Authors: Anna Tyumentseva; Anton Averchuk; Nadezhda Palkina; Ivan Zinchenko; Anton Moshev; Andrey Savchenko; Tatiana Ruksha Journal: Front Oncol Date: 2021-12-03 Impact factor: 6.244
Authors: Alessandra Buja; Massimo Rugge; Giovanni Damiani; Giuseppe De Luca; Manuel Zorzi; Riccardo Fusinato; Chiara De Toni; Antonella Vecchiato; Paolo Del Fiore; Francesca Falasco; Romina Spina; Carlo Riccardo Rossi; Simone Mocellin Journal: Front Public Health Date: 2022-03-31